Verve Therapeutics, Inc.
VERV
•Stock Analysis$11.13
+0.00 (+0.00%)• Live
Verve Therapeutics, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
No chart data available
We couldn't find any historical price data for VERV in the selected time range.
Key Financial Metrics
for Verve Therapeutics, Inc.
P/E Ratio
-3.07
Revenue Growth
+174.98%
EPS Growth
+24.36%
Market Cap
$0.57B
Dividend Yield
0.00%
Debt/Equity
0.14
ROIC
-36.43%
FCF Yield
-25.80%
View additional metrics
Valuation
P/B Ratio1.17
EV/Sales9.09
Financial Health
Current Ratio9.84
Return on Assets-29.47%
Analyst Recommendations
for Verve Therapeutics, Inc.
13 analysts
Consensus: Hold
About
for Verve Therapeutics, Inc.
Company Details
for Verve Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Sekar Kathiresan
Employees
274
Market Cap
994.04M
Exchange
NASDAQ Global Select
IPO Date
June 17, 2021
Website
www.vervetx.comCIK
0001840574
ISIN
US92539P1012
CUSIP
92539P101
Country
US
Balance Sheet
for Verve Therapeutics, Inc.
Cash Flow Statement
for Verve Therapeutics, Inc.
Income Statement
for Verve Therapeutics, Inc.
News
No news available at the moment.